insights_auto
Why is URGN down 2.46%?
Dive Deeperchevron_right
URGN:NASDAQ
Urogen Pharma Ltd
$33.71
arrow_downward
-2.46%(-0.85) 1D
Oct 19, 2:31:32 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for URGN...
Open
$34.75
High
$35.48
Low
$33.40
Mkt. cap
1.65B
Avg. vol.
915.27K
Volume
422.54K
52-wk high
$50.81
52-wk low
$16.36
EPS
-$1.98
Beta
1.57
Shares outstanding
48.88M
No. of employees
300
Open
$34.75
High
$35.48
Low
$33.40
Mkt. cap
1.65B
Avg. vol.
915.27K
Volume
422.54K
52-wk high
$50.81
52-wk low
$16.36
EPS
-$1.98
Beta
1.57
Shares outstanding
48.88M
No. of employees
300
News stories
From web sources and news partners
GuruFocus
·
2 hours ago
URGN Reiterated by HC Wainwright & Co. -- Price Target Maintained at $75
Investing.com
·
6 hours ago
FDA accepts UroGen’s drug application for bladder cancer
Stock Titan
·
6 hours ago
A bladder cancer drug candidate had a 77.8% complete response rate at three months.
About Urogen Pharma Ltd
CEO-
Employees300
Founded2004
HeadquartersNew York, New York, United States
SectorBiotechnology
Websiteurogen.com